Evidence map›Paper›PMID 40399610›Full record

ArticleNature immunology2025

Enhanced antiviral innate immunity supports the bat reservoir of Marburg virus.

Jennifer Tisoncik-Go, Michael Gale

Abstract read
In one paragraph

Article in Nature immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jennifer Tisoncik-GoDepartment of Immunology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-1381-265X
Michael GaleDepartment of Microbiology and Immunology, and Institute on Infectious Diseases, University of Minnesota School of Medicine, Minneapolis, MN, USA. mgale@umn.edu.ORCID http://orcid.org/0000-0002-6332-7436

Funding

University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
Project 2: Systems biology analyses of RHCMV/SIV and IL-15 mechanisms of immune programmingP01AI177688 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale · 2023 to 2026
$8.1M
Innate Immunity to West Nile VirusR01AI179722 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, Andrew Atwell Oberst · 2024 to 2026
$2.6M
Innate Immune Mechanisms Controlling Flavivirus NeurovirulenceR01AI183793 · NIAID · UNIVERSITY OF MINNESOTA · PI Michael Gale, Andrew Atwell Oberst · 2024 to 2026
$2.4M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI151698Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI177688Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI179722Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AII83793NIAID NIH HHS P01 AI177688NIAID NIH HHS R01 AI179722NIAID NIH HHS R01 AI183793NIAID NIH HHS U01 AI151698
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40399610
PMCPMC13037565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.